Sherin and Lodgen LLP has recently obtained a $15.7 million patent infringement verdict for Haemonetics Corporation, a healthcare company. A federal court jury on January 30, following a seven-day trial and two days of deliberations, ordered Fenwal, Inc. to pay $15.7 million in damages for violating a patent on technology for collecting blood. Haemonetics is a US-based company headquarted in Massachusetts.
Haemonetics asserted that Fenwal’s blood collecting device infringed its patent for an automated blood collection system.
The case was heard in the U.S. District Court for Massachusetts (No. 05-12572).
James W. Matthews, lead trial attorney in the case and a partner in Sherin and Lodgen’s Litigation Department, said, “the firm’s in depth knowledge of the medical device industry enabled us to present the complex issues to the jury in a clear and convincing way. That understanding also allowed us to develop a winning strategy in advance of trial.”
Ronald W. Ruth, managing partner of Sherin and Lodgen, said the verdict reflects the ability of the firm’s Litigation Department to handle complex cases.
“We offer sophisticated advice and top-notch litigation expertise to our clients,” Ruth said, “while making sure the case is handled efficiently and responsively.”
Matthews was assisted by Sherin and Lodgen attorneys Margaret H. Paget and Katy E. Koski, as well as co-counsel Martin O’Donnell of Cesari and McKenna LLP in Boston.